Registered with SFDA (Saudi Arabia) for monelukast. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Registered with SFDA (Saudi Arabia) for monelukast. Its GMP is recognised in 5 markets.
Registered with SFDA (Saudi Arabia) for monelukast. Its GMP is recognised in 2 markets.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for monelukast and what filings they hold.
Chat with Fred, your AI analyst